Stovickova L, Hansikova H, Hanzalova J, Musova Z, Semjonov V, Stovicek P
J Neurol. 2024; 271(6):3439-3454.
PMID: 38520521
PMC: 11136723.
DOI: 10.1007/s00415-024-12223-5.
Ast T, Itoh Y, Sadre S, McCoy J, Namkoong G, Wengrod J
Mol Cell. 2024; 84(2):359-374.e8.
PMID: 38199006
PMC: 11046306.
DOI: 10.1016/j.molcel.2023.12.016.
Doni D, Cavion F, Bortolus M, Baschiera E, Muccioli S, Tombesi G
Cell Death Dis. 2023; 14(12):805.
PMID: 38062036
PMC: 10703789.
DOI: 10.1038/s41419-023-06320-y.
Huang H, Shakkottai V
Life (Basel). 2023; 13(6).
PMID: 37374132
PMC: 10302946.
DOI: 10.3390/life13061350.
Mistretta M, Farini A, Torrente Y, Villa C
Brain. 2023; 146(6):2227-2240.
PMID: 36729638
PMC: 10232254.
DOI: 10.1093/brain/awad014.
Ferroptosis Signaling in Pancreatic β-Cells: Novel Insights & Therapeutic Targeting.
Elumalai S, Karunakaran U, Moon J, Won K
Int J Mol Sci. 2022; 23(22).
PMID: 36430158
PMC: 9690757.
DOI: 10.3390/ijms232213679.
The smoothened agonist SAG reduces mitochondrial dysfunction and neurotoxicity of frataxin-deficient astrocytes.
Vicente-Acosta A, Gimenez-Cassina A, Diaz-Nido J, Loria F
J Neuroinflammation. 2022; 19(1):93.
PMID: 35413853
PMC: 9006607.
DOI: 10.1186/s12974-022-02442-w.
Mice harboring the FXN I151F pathological point mutation present decreased frataxin levels, a Friedreich ataxia-like phenotype, and mitochondrial alterations.
Medina-Carbonero M, Sanz-Alcazar A, Britti E, Delaspre F, Cabiscol E, Ros J
Cell Mol Life Sci. 2022; 79(2):74.
PMID: 35038030
PMC: 8763788.
DOI: 10.1007/s00018-021-04100-5.
Targeting Oxidative Stress, NLRP3 Inflammasome, and Autophagy by Fraxetin to Combat Doxorubicin-Induced Cardiotoxicity.
Kabel A, Salama S, Adwas A, Estfanous R
Pharmaceuticals (Basel). 2021; 14(11).
PMID: 34832970
PMC: 8621693.
DOI: 10.3390/ph14111188.
Fe-S Protein Synthesis in Green Algae Mitochondria.
Gomez-Casati D, Busi M, Barchiesi J, Pagani M, Marchetti-Acosta N, Terenzi A
Plants (Basel). 2021; 10(2).
PMID: 33494487
PMC: 7911964.
DOI: 10.3390/plants10020200.
Molecular Defects in Friedreich's Ataxia: Convergence of Oxidative Stress and Cytoskeletal Abnormalities.
Smith F, Kosman D
Front Mol Biosci. 2020; 7:569293.
PMID: 33263002
PMC: 7686857.
DOI: 10.3389/fmolb.2020.569293.
Mitochondrial Carriers Regulating Insulin Secretion Profiled in Human Islets upon Metabolic Stress.
Jimenez-Sanchez C, Brun T, Maechler P
Biomolecules. 2020; 10(11).
PMID: 33198243
PMC: 7697104.
DOI: 10.3390/biom10111543.
Effect of Mitochondrial and Cytosolic FXN Isoform Expression on Mitochondrial Dynamics and Metabolism.
Agro M, Diaz-Nido J
Int J Mol Sci. 2020; 21(21).
PMID: 33158039
PMC: 7662637.
DOI: 10.3390/ijms21218251.
Oxidative stress modulates rearrangement of endoplasmic reticulum-mitochondria contacts and calcium dysregulation in a Friedreich's ataxia model.
Rodriguez L, Calap-Quintana P, Lapena-Luzon T, Pallardo F, Schneuwly S, Navarro J
Redox Biol. 2020; 37:101762.
PMID: 33128998
PMC: 7585950.
DOI: 10.1016/j.redox.2020.101762.
Antioxidant Therapies and Oxidative Stress in Friedreich´s Ataxia: The Right Path or Just a Diversion?.
Rodriguez L, Lapena T, Calap-Quintana P, Molto M, Gonzalez-Cabo P, Navarro Langa J
Antioxidants (Basel). 2020; 9(8).
PMID: 32722309
PMC: 7465446.
DOI: 10.3390/antiox9080664.
Role of frataxin protein deficiency and metabolic dysfunction in Friedreich ataxia, an autosomal recessive mitochondrial disease.
Clark E, Johnson J, Dong Y, Mercado-Ayon E, Warren N, Zhai M
Neuronal Signal. 2020; 2(4):NS20180060.
PMID: 32714592
PMC: 7373238.
DOI: 10.1042/NS20180060.
Phosphodiesterase Inhibitors Revert Axonal Dystrophy in Friedreich's Ataxia Mouse Model.
Molla B, Munoz-Lasso D, Calap P, Fernandez-Vilata A, Iglesia-Vaya M, Pallardo F
Neurotherapeutics. 2019; 16(2):432-449.
PMID: 30761510
PMC: 6554462.
DOI: 10.1007/s13311-018-00706-z.
Plant Frataxin in Metal Metabolism.
Gomez-Casati D, Busi M, Pagani M
Front Plant Sci. 2018; 9:1706.
PMID: 30519254
PMC: 6258813.
DOI: 10.3389/fpls.2018.01706.
Iron in Friedreich Ataxia: A Central Role in the Pathophysiology or an Epiphenomenon?.
Alsina D, Purroy R, Ros J, Tamarit J
Pharmaceuticals (Basel). 2018; 11(3).
PMID: 30235822
PMC: 6161073.
DOI: 10.3390/ph11030089.
Impact of Models in the Study and Treatment of Friedreich's Ataxia.
Monnier V, Llorens J, Navarro J
Int J Mol Sci. 2018; 19(7).
PMID: 29986523
PMC: 6073496.
DOI: 10.3390/ijms19071989.